TY - JOUR
T1 - Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions
AU - Leone, Marc
AU - Boyle, Walter A.
PY - 2006/4
Y1 - 2006/4
N2 - Objective: To determine the effect of vasodilatory septic shock-like conditions on vasoconstricting responses to vasopressin and norepinephrine in isolated resistance arteries. Design: Prospective, randomized animal study. Setting: University research laboratory. Subjects: Male adult Sprague-Dawley rats. Interventions: Small mesenteric arteries (outside diameter, 50-150 μm) were cannulated and studied in vitro under physiologic conditions. A vasodilatory septic shock-like state was produced by treatment with the nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP), and the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX). Vasoconstricting concentration-response relationships were determined for norepinephrine and vasopressin before and after application of SNAP or SNAP+ IBMX. Synergism between low-dose vasopressin and norepinephrine and between low-dose norepinephrine and vasopressin was determined before and after SNAP or SNAP+IBMX. Main Results: Norepinephrine and vasopressin produced concentration-dependent contractions (half-maximal effective concentration [EC50] = 2.5 μM, and 3.9 nM, respectively) that were significantly inhibited by 1 μM SNAP (EC50 = 3.6 μM and 8.1 nM, respectively) or 100 μM SNAP + 10 μM IBMX (EC50 = 10 μM and 8.2 nM, respectively). Low-dose vasopressin significantly increased the responsiveness to norepinephrine (EC50 = 0.5 μM) just as a low-dose norepinephrine significantly enhanced the vasopressin response (EC 50 = 2.3 nM). The synergistic effects of low-dose vasopressin and norepinephrine, or low-dose norepinephrine and vasopressin, were also significantly inhibited by 1 μM SNAP (EC50 = 2.5 μM and 4.2 nM, respectively) or 100 μM SNAP + 10 μM IBMX (EC50 = 9 μM and 8.4 nM, respectively). Conclusions: Vasoconstriction produced by vasopressin or norepinephrine, and the synergistic vasoconstriction produced by the combinations, was inhibited in vasodilatory septic shock-like conditions. Thus, in addition to the well-described vasopressin deficiency in vasodilatory septic shock, these studies indicate that decreased vasopressin responsiveness further contributes to a state of relative vasopressin insufficiency in this condition.
AB - Objective: To determine the effect of vasodilatory septic shock-like conditions on vasoconstricting responses to vasopressin and norepinephrine in isolated resistance arteries. Design: Prospective, randomized animal study. Setting: University research laboratory. Subjects: Male adult Sprague-Dawley rats. Interventions: Small mesenteric arteries (outside diameter, 50-150 μm) were cannulated and studied in vitro under physiologic conditions. A vasodilatory septic shock-like state was produced by treatment with the nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP), and the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX). Vasoconstricting concentration-response relationships were determined for norepinephrine and vasopressin before and after application of SNAP or SNAP+ IBMX. Synergism between low-dose vasopressin and norepinephrine and between low-dose norepinephrine and vasopressin was determined before and after SNAP or SNAP+IBMX. Main Results: Norepinephrine and vasopressin produced concentration-dependent contractions (half-maximal effective concentration [EC50] = 2.5 μM, and 3.9 nM, respectively) that were significantly inhibited by 1 μM SNAP (EC50 = 3.6 μM and 8.1 nM, respectively) or 100 μM SNAP + 10 μM IBMX (EC50 = 10 μM and 8.2 nM, respectively). Low-dose vasopressin significantly increased the responsiveness to norepinephrine (EC50 = 0.5 μM) just as a low-dose norepinephrine significantly enhanced the vasopressin response (EC 50 = 2.3 nM). The synergistic effects of low-dose vasopressin and norepinephrine, or low-dose norepinephrine and vasopressin, were also significantly inhibited by 1 μM SNAP (EC50 = 2.5 μM and 4.2 nM, respectively) or 100 μM SNAP + 10 μM IBMX (EC50 = 9 μM and 8.4 nM, respectively). Conclusions: Vasoconstriction produced by vasopressin or norepinephrine, and the synergistic vasoconstriction produced by the combinations, was inhibited in vasodilatory septic shock-like conditions. Thus, in addition to the well-described vasopressin deficiency in vasodilatory septic shock, these studies indicate that decreased vasopressin responsiveness further contributes to a state of relative vasopressin insufficiency in this condition.
KW - Nitric oxide
KW - Norepinephrine
KW - Resistance artery
KW - Vasopressin
UR - http://www.scopus.com/inward/record.url?scp=33645815517&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000206466.56669.BE
DO - 10.1097/01.CCM.0000206466.56669.BE
M3 - Article
C2 - 16484914
AN - SCOPUS:33645815517
SN - 0090-3493
VL - 34
SP - 1126
EP - 1130
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 4
ER -